LIVER INTERNATIONAL
Scope & Guideline
Connecting researchers and practitioners in the fight against liver disease.
Introduction
Aims and Scopes
- Metabolic Liver Disorders:
The journal consistently explores metabolic dysfunction-associated liver diseases (MAFLD) and its implications, emphasizing the relationship between metabolic syndrome, liver health, and overall patient outcomes. - Viral Hepatitis Research:
A significant portion of the publications focuses on hepatitis B and C, including new treatment strategies, epidemiology, and the challenges of achieving viral eradication and elimination. - Innovative Diagnostic Techniques:
Liver International highlights advancements in diagnostic methodologies, including non-invasive imaging and biomarkers, to assess liver disease progression and treatment efficacy. - Liver Cancer Studies:
Research on hepatocellular carcinoma (HCC) is a major focus, encompassing topics from early diagnosis and prognostic factors to treatment outcomes and novel therapeutic strategies. - Clinical Management and Guidelines:
The journal provides insights into clinical practices, treatment guidelines, and the integration of multidisciplinary approaches to improve liver disease management. - Socioeconomic and Public Health Impacts:
Articles often address the socioeconomic factors affecting liver disease prevalence and treatment access, highlighting disparities among different populations. - Drug-Induced Liver Injury:
The journal discusses the mechanisms and implications of drug-induced liver injury, providing insights into prevention, diagnosis, and management. - Emerging Therapies and Clinical Trials:
Research on new therapeutic agents and clinical trials is a recurring theme, focusing on innovative treatments for various liver diseases, including antiviral therapies and immunotherapies.
Trending and Emerging
- Metabolic Dysfunction and Liver Disease:
There is a significant increase in research focused on metabolic dysfunction-associated fatty liver disease (MAFLD) and its relationship with obesity, diabetes, and cardiovascular health. - Artificial Intelligence and Machine Learning Applications:
Emerging studies are increasingly applying AI and machine learning to predict liver disease outcomes, enhance diagnostic accuracy, and optimize treatment strategies. - Health Disparities and Social Determinants:
A growing body of work is examining the impact of socioeconomic factors on liver disease prevalence and treatment access, emphasizing the need for equitable healthcare solutions. - Long-term Outcomes Following Viral Hepatitis Treatment:
Increasing attention is being paid to the long-term outcomes of patients treated for chronic hepatitis B and C, including the risk of liver cancer and reinfection. - Integration of Gut Microbiome Research:
Research exploring the gut-liver axis and its implications for liver disease is on the rise, focusing on how gut health influences liver conditions. - Immunotherapy in Liver Cancer:
There is a notable trend toward investigating immunotherapeutic approaches for treating hepatocellular carcinoma, reflecting advancements in cancer treatment. - Non-invasive Monitoring Techniques:
The development and validation of non-invasive tools for assessing liver stiffness and fibrosis are gaining momentum, providing alternatives to traditional biopsy.
Declining or Waning
- Traditional Liver Biopsy Techniques:
There is a noticeable decline in studies focused on conventional liver biopsy techniques as non-invasive methods gain favor for diagnosing liver diseases. - Acute Liver Failure Studies:
Research specifically targeting acute liver failure has waned, possibly due to the increasing focus on chronic liver diseases and their long-term management. - Alcohol-Related Liver Disease Studies:
The frequency of publications solely addressing alcohol-related liver disease has decreased, which may reflect a broader shift toward understanding metabolic and multifactorial liver diseases. - Hepatitis E Research:
Interest in hepatitis E research appears to be declining, with fewer studies published in recent years as other liver diseases gain more attention.
Similar Journals
SEMINARS IN LIVER DISEASE
Elevating the discourse in liver disease management.SEMINARS IN LIVER DISEASE is a premier journal dedicated to advancing the field of hepatology, published by THIEME MEDICAL PUBL INC. Established in 1981, it has become a respected resource within the academic community, providing high-quality peer-reviewed articles that cover a broad range of topics related to liver diseases. With an impressive impact factor and recognized as a Q1 journal in the hepatology category, it ranks 17th out of 82 journals in the field, placing it in the top 21% of its category according to Scopus rankings. Although it does not offer open access, the journal’s rigorous standards and extensive network ensure that it reaches a wide audience of clinicians, researchers, and students, fostering knowledge and innovation in liver disease management. The journal's objectives focus on disseminating critical insights and promoting informed discussions that can pave the way for future research and clinical advancements in hepatology.
International Journal of Hepatology
Unveiling critical research to transform liver care.The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.
Liver Cancer
Fostering collaboration in the fight against liver cancer.Liver Cancer is a premier, peer-reviewed journal dedicated to the comprehensive study and advancement of knowledge surrounding liver neoplasms. Published by KARGER and headquartered in Switzerland, this journal has been an open-access platform since 2012, providing researchers with invaluable insights into the rapidly evolving field of hepatology and oncology. With an impressive impact factor that places it in the Q1 category for both Hepatology and Oncology in 2023, Liver Cancer stands out as a high-impact conduit for groundbreaking research, ranking #19 out of 404 in Medicine _ Oncology and #6 out of 82 in Medicine _ Hepatology according to Scopus. Researchers, practitioners, and students are encouraged to engage with the journal's content, which encompasses clinical studies, basic research, and reviews that contribute significantly to understanding liver cancer dynamics, diagnosis, and treatment strategies. This journal not only facilitates the dissemination of knowledge but also fosters collaboration in a well-established and impactful global scientific community.
Saudi Journal of Gastroenterology
Unlocking insights into gastrointestinal health.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
Korean Journal of Gastroenterology
Fostering Global Dialogue on Digestive HealthKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
HEPATOLOGY
Leading the way in liver disease research and clinical practice.HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.
WORLD JOURNAL OF GASTROENTEROLOGY
Elevating research in gastrointestinal medicine.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.
Clinics in Liver Disease
Navigating the landscape of liver health and disease.Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.
Hepatobiliary Surgery and Nutrition
Pioneering research in liver and biliary wellness.Hepatobiliary Surgery and Nutrition is a leading journal dedicated to advancing the fields of hepatobiliary surgery and nutritional science, published by AME Publishing Company. With a commitment to disseminate high-quality research, this journal serves as a vital platform for clinicians, researchers, and students alike to share their findings and insights related to liver and biliary health. The journal operates under an Open Access model, ensuring that cutting-edge research is readily available to a global audience. Although specific rankings and impact factors are currently not provided, the journal's focus on innovative surgical techniques and nutritional strategies underscores its importance in improving patient outcomes and shaping future practices in hepatobiliary medicine. Situated in Hong Kong, Hepatobiliary Surgery and Nutrition invites submissions that push the boundaries of knowledge in these crucial areas, fostering a collaborative environment for advancement in surgery and nutrition.
Canadian Journal of Gastroenterology and Hepatology
Fostering Collaboration in Gastrointestinal and Liver StudiesCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.